CountryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua & BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia & HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCentral African RepublicChadChileChinaColombiaComorosCongoCongo Democratic RepublicCosta RicaCote d'IvoireCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEast TimorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFijiFinlandFranceGabonGambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKorea NorthKorea SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalThe NetherlandsNew ZealandNicaraguaNigerNigeriaNorwayOmanPakistanPalauPalestinian State*PanamaPapua New GuineaParaguayPeruThe PhilippinesPolandPortugalQatarRomaniaRussiaRwandaSt. Kitts & NevisSt. LuciaSt. Vincent & The GrenadinesSamoaSan MarinoSao Tome & PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth SudanSpainSri LankaSudanSurinameSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad & TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States of AmericaUruguayUzbekistanVanuatuVatican City (Holy See)VenezuelaVietnamYemenZambiaZimbabwe
Multi User License - $2,500
Coming Soon
The Australian medical device market is developed, and its regulatory framework is well-established. However, in the upcoming years, it will have one of the South Pacific region’s slowest rates of growth.
A large percentage of the medical equipment used in Australia is imported. Subsidiaries of major international firms govern the nation’s industrial sector.
The healthcare sector in Australia is developed and open to new products. A wide variety of medical devices are always in demand, especially those made to treat and control illnesses linked to ageing. Since the Australian market is driven by the need to manage costs, imported products are frequently cutting-edge and economical.
Devices that treat chronic pain, and disabilities, and speed up healing are also in greater demand. From a regulatory perspective, the Australian market is relatively open to products that have previously received the CE Mark.
The Australia Medical Devices Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
New therapies for patients with diseases including epilepsy, Parkinson’s disease, hearing loss, stroke, and diabetes are expected to go forward more quickly with the opening of Australia’s first medical device development and production center in Melbourne.
The Bionics Institute and the University of Melbourne recently opened a new facility called Neo-Bionica. It is a highly specialized laboratory that was specially designed with the most up-to-date cleanroom technology, cutting-edge robotic equipment, improved 3D printing, and highly precise equipment needed to develop prototypes and manufacture medical devices for clinical trials.
Through commercialization, innovation, and research, Texas Medical Center (TMC) and Biodesign Australia will advance health and life science research. Founders and entrepreneurs will have access to talent, clinical trial activity, expanded funding opportunities, and market access thanks to the collaboration between TMC and Biodesign Australia.
TMC Biodesign will be able to better connect with programmes in the Biodesign Australia network as a result of this partnership. An avenue for Australian digital health and medical device firms to interact with Texas Medical Center Innovation programmes and partners has been co-designed by the TMC | Australia Biobridge.
Baxter Healthcare (Baxter), a world leader in clinical nutrition, and Micrel Medical Devices, a medical device firm specializing in infusion treatment, have announced a partnership for the sale of the Micrel Mini Rythmic PN+ infusion pump for parenteral nutrition (PN).
According to the deal, Baxter Healthcare will be Australia and New Zealand’s sole distributor of the Micrel Mini Rythmic PN+ infusion pump and its accessories.
Braun Australia, a top supplier of cutting-edge medical goods and services for the healthcare sector, recently announced that it has joined forces with Demic Infection Control Stations (Demic ICS) in a strategic alliance to offer a cutting-edge hand hygiene solution for the international healthcare market.
The partnership gives B. Braun exclusive distribution rights for Demics ICS’s Concierge hand sanitiser dispensing system, which will use B. Braun’s Softa-Man hand sanitisers, in the healthcare industry.
For hygienic and surgical hand preparation, B. Braun’s Softa-Man antiseptic hand rub has been shown to be effective against bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), mycobacteria, fungi, enveloped viruses, and rotavirus.
